A Phase 3 Double-masked, Randomized, Multicenter Study of the Efficacy and Safety of OCS 01 Eye Drops in Subjects with Diabetic Macular Edema. - (DIAMOND-2)
A phase 2/3 double-masked, randomized, 2 stage, multicenter study of the efficacy and safety of OCS-01 eye drops in subjects with diabetic macular edema. - (Diamond-1)
A 26 Week, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Phase 3 Trial with a 26 Week Safety Extension Period Evaluating the Safety and Efficacy of Dapagliflozin 5 and 10 mg, and Saxagliptin 2.5 and 5 mg in Pediatric Patients with Type 2 Diabetes Mellitus who are between 10 and below 18 years of age
100 项与 Pharmaceutical Research Associates India Pvt Ltd. 相关的临床结果
0 项与 Pharmaceutical Research Associates India Pvt Ltd. 相关的专利(医药)
100 项与 Pharmaceutical Research Associates India Pvt Ltd. 相关的药物交易
100 项与 Pharmaceutical Research Associates India Pvt Ltd. 相关的转化医学